Histological regression of giant cell tumor of bone following RANK ligand inhibition

Martin F. Dietrich, Dominick Cavuoti, Michael Landay, Yull E. Arriaga

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.

Original languageEnglish (US)
JournalJournal of Investigative Medicine High Impact Case Reports
Volume2
Issue number4
DOIs
StatePublished - Nov 14 2014

Keywords

  • Denosumab
  • Giant cell tumor
  • Lung metastases
  • RANK ligand

ASJC Scopus subject areas

  • Epidemiology
  • Safety, Risk, Reliability and Quality
  • Safety Research

Fingerprint

Dive into the research topics of 'Histological regression of giant cell tumor of bone following RANK ligand inhibition'. Together they form a unique fingerprint.

Cite this